Solara Active Pharma Sciences Limited (SOLARA.NS) NSE

543.05

-4.35(-0.79%)

Updated at June 02 03:30PM

Currency In INR

Solara Active Pharma Sciences Limited

Address

Admin Block 27

Chennai, 600127

India

Phone

91 44 4344 6700

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

2156

First IPO Date

June 27, 2018

Key Executives

NameTitlePayYear Born
Sandeep Rao PGDMChief Executive Officer & MD32.56M1973
Neeta DaniSenior Vice President of Sales & Marketing0N/A
MohanrajWhole-Time Director & Chief Human Resources Officer0N/A
V. Sundara MoorthyChief Quality Officer0N/A
Pooja Jaya KumarCompany Secretary & Compliance Officer0N/A
Ganesh MukundanSenior Vice President of Sales & Marketing0N/A
Rajesh PatroChief Risk Officer0N/A
Hero VelladuraiChief Scientific Officer0N/A
Arun Kumar PillaiFounder & Non-Executive Director01961
Raghavan VenkatramaniGeneral Manager of Accounts0N/A
Sarat KumarChief Financial Officer & Chief Investor Relations Officer0N/A
Vishal MathurChief Commercial Officer0N/A

Description

Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India. The company offers APIs for anesthetics, anthelmintic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-viral, antibiotic, anticoagulant, anticonvulsant, antidepressant, antiemetic, antiepileptic, antifungal, antigout agent, antihistamine, antihyperlipoproteinemic, antimalarial, antimycotic, antineoplastic detoxifying agent, antiprotozoal agent, antipsoriatic, antipsychotic, antitubercular, antitussive, antiulcerative, anxiolytic, bile acid analogue, calcimimetic agent, cardiovascular agent, central nervous system agent, chronic alcoholism, chronic kidney disease, dopamine receptor antagonist, folate analog, hyperkalaemia, immunosuppressant, lipid regulating agent, loop diuretic, muscarinic agonist, neuromuscular, OAB treatment, phenylalanine reducer, recovery of stroke, tardive dyskinesia, treatment of glaucoma and hyperphosphatemia, tropical anti-infective, and type-II diabetes therapeutic categories. It also provides contract research and manufacturing services for APIs, including contract development and manufacturing, analytical services, impurity synthesis, and regulatory support. In addition, the company exports its products. It operates in the Asia Pacific, Europe, North America, South America, and internationally. The company was formerly known as SSL Pharma Sciences Limited and changed its name to Solara Active Pharma Sciences Limited in March 2017. Solara Active Pharma Sciences Limited was incorporated in 2017 and is based in Chennai, India.